Global Pharma-Bio Industry Wraps up $5.5 billion in Projects During 1Q19, an Industrial Info Market Brief
Attachment: Pharma
During the first three months of 2019, the global pharma-bio industry completed 564 capital and maintenance projects. Representing $5.5 billion in total investment, the activity ranged from annual scheduled maintenance events to major production unit additions. One notable project was the completion of Pfizer's $200 million investment featuring single use systems (SUS) to add five production lines for Bulk Pharmaceuticals and APIs (aka DSI-Drug Substance Intermediates) at its Andover, Maryland, site. Project team members included CRB Consulting Engineers Incorporated, Lend Lease and Biotech Builders. Click here for the list of projects completed in the first quarter and see map below.
